Last week’s MM&M webcast titled “From Selling Pills to Selling Health Outcomes” was packed with thought provoking material. Joining the podcast were Daniel Hawkins (Clarion Healthcare Consulting), Dennis Urbaniak (Sanofi-Aventis) and Dan Rubin (inVentiv Patient …
Read the full story »
You know the big-pharma club is in trouble when most of its members are jumping ship from fighting against generics to producing generics themselves. Novartis, GSK, Sanofi and Daiichi are just a few examples of …
Although we’ve seen a huge increase in the number of clients going straight to purchasing white-label formulations products, basically the switch for European generics companies from manufacturing to marketing, CEE markets still have low manufacturing …
![Big pharma grows a [heart] ?](http://www.alensagenerics.com/wp-content/themes/arthemia-premium/scripts/timthumb.php?src=http://www.alensagenerics.com/wp-content/uploads/2009/02/heart-in-hands-300x295.jpg&w=80&h=80&zc=1&q=100)
